Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
- IceCure Medical Ltd (NASDAQ:ICCM) rose 36.5% to $3.89 in pre-market trading. IceCure Medical, last week, received notice of intention to grant a European patent covering its cryogenic pump.
- American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 25.8% to $2.39 in pre-market trading after dipping 24% on Thursday.
- RISE Education Cayman Ltd (NASDAQ:REDU) rose 15.3% to $0.6106 in pre-market trading following a 5% surge on Thursday.
- Genocea Biosciences, Inc. (NASDAQ:GNCA) shares rose 12.5% to $1.40 in pre-market trading after gaining around 20% on Thursday.
- Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) rose 9.8% to $2.90 in pre-market trading. Aridis Pharmaceuticals, last week, announced its fully human monoclonal antibody cocktail AR-701 is broadly reactive against the Omicron and other COVID-19 variants, SARS, MERS and the common cold coronaviruses.
- Orbsat Corp. (NASDAQ:OSAT) rose 8.4% to $4.01 in pre-market trading after dropping over 5% on Thursday. The company, last month, reported Q3 sales of $2.25 million.
- Nxt-ID, Inc. (NASDAQ:NXTD) rose 7% to $4.29 in pre-market trading after surging around 20% on Thursday.
- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) rose 6% to $3.88 in pre-market trading after tumbling 12% on Thursday.
- XpresSpa Group, Inc. (NASDAQ:XSPA) rose 5.5% to $2.11 in pre-market trading.
- Gevo, Inc. (NASDAQ:GEVO) shares rose 5.4% to $5.10 in pre-market trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) fell 15.1% to $2.36 in pre-market trading after the company reported a proposed underwritten public offering of American Depositary Shares.
- Snow Lake Resources Ltd. (NASDAQ:LITM) shares fell 5.9% to $5.46 in pre-market trading after dropping over 3% on Thursday.
- Genfit SA (NASDAQ:GNFT) fell 5.9% to $5.08 in pre-market trading. Genfit and Ipsen recently announced an exclusive licensing agreement for elafibranor.
- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares fell 5.2% to $0.43 in pre-market trading. Chardan Capital, last week, maintained Sonnet BioTherapeutics with a Buy and lowered the price target from $8 to $2.5.
- Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares fell 4.3% to $4.90 in pre-market trading. Ensysce Biosciences recently said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!